The National Pharmaceutical Pricing Authority on July 10 notified price control on 50 new drugs and the order will reduce the drug prices by 10-35 percent.
The government's decision to control therapeutic drug prices has unsettled many in the industry. Latest to voice his concern is Aijaz Tobaccowala, managing director, Pfizer India .
Tobaccowala said that the new pricing order had caught the company completely by surprise, and will wait for more clarity before making on-ground changes.
Also read: NPPA's unilateral stand-off unhealthy for sector: Biocon
Speaking to CNBC-TV18's Archana Shukla Tobaccowala said, "one of the things we always looked for was a certain amount of consultation with the industry before decisions are taken. All I can look forward to is rounds of consultation with the industry before any additional decisions are taken."
The National Pharmaceutical Pricing Authority on July 10 notified price control on 50 new drugs and the order will reduce the drug prices by 10-35 percent.
Pfizer stock price
On August 08, 2014, Pfizer closed at Rs 1330.30, down Rs 5.35, or 0.4 percent. The 52-week high of the share was Rs 1779.00 and the 52-week low was Rs 1004.10.
The company's trailing 12-month (TTM) EPS was at Rs 73.51 per share as per the quarter ended June 2014. The stock's price-to-earnings (P/E) ratio was 18.1. The latest book value of the company is Rs 641.82 per share. At current value, the price-to-book value of the company is 2.07.
Anda sedang membaca artikel tentang
New pricing order caught us by surprise: Pfizer India MD
Dengan url
http://gayafashionshow.blogspot.com/2014/08/new-pricing-order-caught-us-by-surprise.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
New pricing order caught us by surprise: Pfizer India MD
namun jangan lupa untuk meletakkan link
New pricing order caught us by surprise: Pfizer India MD
sebagai sumbernya
0 komentar:
Posting Komentar